{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:14:17Z","timestamp":1794003257985,"version":"4.8.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-024-02167-x","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T22:32:50Z","timestamp":1732919570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Cancer treatment-related xerostomia: basics, therapeutics, and future perspectives"],"prefix":"10.1186","volume":"29","author":[{"given":"Mohammad-Salar","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvin","family":"Sanaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ata","family":"Mahmoodpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Jabbari Beyrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Jabbari Beyrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Fattahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Jahanshahlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Zarei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Rahimi Mamaghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid","family":"Kuchaki Rafsanjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,30]]},"reference":[{"issue":"3","key":"2167_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1834-7819.2010.01229.x","volume":"55","author":"MS Hopcraft","year":"2010","unstructured":"Hopcraft MS, Ceaser T. Xerostomia: an update for clinicians. Aust Dental J. 2010;55(3):238\u201344.","journal-title":"Aust Dental J."},{"key":"2167_CR2","doi-asserted-by":"publisher","DOI":"10.1590\/1807-3107BOR-2017.vol31.0014","volume":"31","author":"S Niklander","year":"2017","unstructured":"Niklander S, Veas L, Barrera C, Fuentes F, Chiappini G, Marshall M. Risk factors, hyposalivation and impact of xerostomia on oral health-related quality of life. Braz Oral Res. 2017;31: e14. https:\/\/doi.org\/10.1590\/1807-3107BOR-2017.vol31.0014.","journal-title":"Braz Oral Res"},{"issue":"4","key":"2167_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.4103\/2141-9248.139284","volume":"4","author":"H Mortazavi","year":"2014","unstructured":"Mortazavi H, Baharvand M, Movahhedian A, Mohammadi M, Khodadoustan A. Xerostomia due to systemic disease: a review of 20 conditions and mechanisms. Ann Med Health Sci Res. 2014;4(4):503\u201310. https:\/\/doi.org\/10.4103\/2141-9248.139284.","journal-title":"Ann Med Health Sci Res"},{"key":"2167_CR4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1590\/1516-3180.2020.0616.r3.1902021","volume":"139","author":"CB Fornari","year":"2021","unstructured":"Fornari CB, Bergonci D, Stein CB, Agostini BA, Rigo L. Prevalence of xerostomia and its association with systemic diseases and medications in the elderly: a cross-sectional study. Sao Paulo Med J. 2021;139:380\u20137.","journal-title":"Sao Paulo Med J"},{"issue":"9","key":"2167_CR5","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/joor.12664","volume":"45","author":"AML Pedersen","year":"2018","unstructured":"Pedersen AML, S\u00f8rensen CE, Proctor GB, Carpenter GH, Ekstr\u00f6m J. Salivary secretion in health and disease. J Oral Rehabil. 2018;45(9):730\u201346.","journal-title":"J Oral Rehabil"},{"key":"2167_CR6","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jdent.2018.08.010","volume":"80","author":"AML Pedersen","year":"2019","unstructured":"Pedersen AML, Belstr\u00f8m D. The role of natural salivary defences in maintaining a healthy oral microbiota. J Dentis. 2019;80:S3\u201312.","journal-title":"J Dentis."},{"key":"2167_CR7","doi-asserted-by":"crossref","unstructured":"Konttinen YT, Porcar AV, Porola P, Koskenpato K, Rodriguez ML, P\u00f6ll\u00e4nen R, et al. Neurobiology and hormonal control of lacrimal and salivary gland function. In: Sj\u00f6gren\u2019s syndrome: practical guidelines to diagnosis and therapy. 2012:151-75.","DOI":"10.1007\/978-1-60327-957-4_11"},{"issue":"5","key":"2167_CR8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.clindermatol.2017.06.010","volume":"35","author":"JW Millsop","year":"2017","unstructured":"Millsop JW, Wang EA, Fazel N. Etiology, evaluation, and management of xerostomia. Clin Dermatol. 2017;35(5):468\u201376.","journal-title":"Clin Dermatol"},{"issue":"2","key":"2167_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.archoralbio.2014.10.004","volume":"60","author":"J Saleh","year":"2015","unstructured":"Saleh J, Figueiredo MAZ, Cherubini K, Salum FG. Salivary hypofunction: an update on aetiology, diagnosis and therapeutics. Arch Oral Biol. 2015;60(2):242\u201355.","journal-title":"Arch Oral Biol"},{"issue":"1","key":"2167_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.14219\/jada.archive.2003.0018","volume":"134","author":"J Guggenheimer","year":"2003","unstructured":"Guggenheimer J, Moore PA. Xerostomia: etiology, recognition and treatment. J Am Dental Assoc. 2003;134(1):61\u20139.","journal-title":"J Am Dental Assoc."},{"issue":"10","key":"2167_CR11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.clon.2009.09.002","volume":"21","author":"SA Bhide","year":"2009","unstructured":"Bhide SA, Miah AB, Harrington KJ, Newbold KL, Nutting CM. Radiation-induced xerostomia: pathophysiology, prevention and treatment. Clin Oncol. 2009;21(10):737\u201344. https:\/\/doi.org\/10.1016\/j.clon.2009.09.002.","journal-title":"Clin Oncol"},{"issue":"2","key":"2167_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1556\/2060.2020.00019","volume":"107","author":"OM Einhorn","year":"2020","unstructured":"Einhorn OM, Georgiou K, Tompa A. Salivary dysfunction caused by medication usage. Physiol Int. 2020;107(2):195\u2013208.","journal-title":"Physiol Int."},{"issue":"6","key":"2167_CR13","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.3390\/ijms24065358","volume":"24","author":"YJ Kim","year":"2023","unstructured":"Kim YJ. Xerostomia and its cellular targets. Int J Mol Sci. 2023;24(6):5358. https:\/\/doi.org\/10.3390\/ijms24065358.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2167_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41241-017-0037-5","volume":"37","author":"GC Jaguar","year":"2017","unstructured":"Jaguar GC, Prado JD, Campanh\u00e3 D, Alves FA. Clinical features and preventive therapies of radiation-induced xerostomia in head and neck cancer patient: a literature review. Appl Cancer Res. 2017;37(1):1\u20138.","journal-title":"Appl Cancer Res."},{"issue":"2","key":"2167_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3857\/roj.2020.00213","volume":"38","author":"I Brook","year":"2020","unstructured":"Brook I. Late side effects of radiation treatment for head and neck cancer. Radiat Oncol J. 2020;38(2):84.","journal-title":"Radiat Oncol J"},{"issue":"8","key":"2167_CR16","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/hed.10129","volume":"24","author":"OB Wijers","year":"2002","unstructured":"Wijers OB, Levendag PC, Braaksma MM, Boonzaaijer M, Visch LL, Schmitz PI. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors. Head Neck. 2002;24(8):737\u201347. https:\/\/doi.org\/10.1002\/hed.10129.","journal-title":"Head Neck"},{"key":"2167_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2022.907778","volume":"3","author":"MA Vistoso","year":"2022","unstructured":"Vistoso MA, Polonsky G, Shiboski C, Sankar V, Villa A. Salivary gland dysfunction secondary to cancer treatment. Front Oral Health. 2022;3: 907778. https:\/\/doi.org\/10.3389\/froh.2022.907778.","journal-title":"Front Oral Health"},{"issue":"2","key":"2167_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","volume":"12","author":"CM Nutting","year":"2011","unstructured":"Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12(2):127\u201336. https:\/\/doi.org\/10.1016\/S1470-2045(10)70290-4.","journal-title":"Lancet Oncol"},{"key":"2167_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2022.07.006","volume":"175","author":"H Huang","year":"2022","unstructured":"Huang H, Miao J, Xiao X, Hu J, Zhang G, Peng Y, et al. Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): a prospective phase II randomized controlled study. Radiothera Oncol. 2022;175:1\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2022.07.006.","journal-title":"Radiothera Oncol"},{"issue":"2","key":"2167_CR20","first-page":"623","volume":"34","author":"F De Felice","year":"2020","unstructured":"De Felice F, Pranno N, Papi P, Brugnoletti O, Tombolini V, Polimeni A. Xerostomia and clinical outcomes in definitive intensity modulated radiotherapy (IMRT) versus three-dimensional conformal radiotherapy (3D-CRT) for head and neck squamous cell carcinoma: a meta-analysis. In vivo (Athens, Greece). 2020;34(2):623\u20139.","journal-title":"In vivo (Athens, Greece)."},{"issue":"3","key":"2167_CR21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1834-7819.2011.01347.x","volume":"56","author":"A Villa","year":"2011","unstructured":"Villa A, Abati S. Risk factors and symptoms associated with xerostomia: a cross-sectional study. Aust Dental J. 2011;56(3):290\u20135.","journal-title":"Aust Dental J."},{"key":"2167_CR22","doi-asserted-by":"publisher","first-page":"7802334","DOI":"10.1155\/2022\/7802334","volume":"2022","author":"Y Li","year":"2022","unstructured":"Li Y, Li X, Pang R, Yang G, Tian M, Zhao T, et al. Diagnosis, prevention, and treatment of radiotherapy-induced xerostomia: a review. J Oncol. 2022;2022:7802334. https:\/\/doi.org\/10.1155\/2022\/7802334.","journal-title":"J Oncol"},{"issue":"1","key":"2167_CR23","doi-asserted-by":"publisher","first-page":"8419","DOI":"10.1038\/s41598-022-12581-y","volume":"12","author":"J Ren","year":"2022","unstructured":"Ren J, Huang R, Li Y, Chen R, Tian H, Liu C. Radioprotective effects and mechanism of HL-003 on radiation-induced salivary gland damage in mice. Sci Rep. 2022;12(1):8419. https:\/\/doi.org\/10.1038\/s41598-022-12581-y.","journal-title":"Sci Rep"},{"issue":"1","key":"2167_CR24","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1186\/s12967-023-04554-0","volume":"21","author":"Z Yu","year":"2023","unstructured":"Yu Z, Xu C, Song B, Zhang S, Chen C, Li C, et al. Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances. J Transl Med. 2023;21(1):708. https:\/\/doi.org\/10.1186\/s12967-023-04554-0.","journal-title":"J Transl Med"},{"issue":"11","key":"2167_CR25","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00432-015-1974-6","volume":"141","author":"JM Straub","year":"2015","unstructured":"Straub JM, New J, Hamilton CD, Lominska C, Shnayder Y, Thomas SM. Radiation-induced fibrosis: mechanisms and implications for therapy. J Cancer Res Clin Oncol. 2015;141(11):1985\u201394. https:\/\/doi.org\/10.1007\/s00432-015-1974-6.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"2167_CR26","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.3390\/jcm9124095","volume":"9","author":"KJ Jasmer","year":"2020","unstructured":"Jasmer KJ, Gilman KE, Mu\u00f1oz Forti K, Weisman GA, Limesand KH. Radiation-induced salivary gland dysfunction: mechanisms, therapeutics and future directions. J Clin Med. 2020;9(12):4095. https:\/\/doi.org\/10.3390\/jcm9124095.","journal-title":"J Clin Med"},{"key":"2167_CR27","first-page":"35","volume":"1","author":"P Athanasios","year":"2017","unstructured":"Athanasios P, Petros P, Dimitrios A. Chemotherapy: oral side effects and dental interventions-a review of the literature. Stomatolog Dis Sci. 2017;1:35\u201349.","journal-title":"Stomatolog Dis Sci"},{"issue":"6","key":"2167_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3322\/caac.21157","volume":"62","author":"JB Epstein","year":"2012","unstructured":"Epstein JB, Thariat J, Bensadoun R-J, Barasch A, Murphy BA, Kolnick L, et al. Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin. 2012;62(6):400\u201322.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2167_CR29","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.3390\/curroncol30050336","volume":"30","author":"L Sardellitti","year":"2023","unstructured":"Sardellitti L, Bortone A, Filigheddu E, Serralutzu F, Milia EP. Xerostomia: from pharmacological treatments to traditional medicine\u2014an overview on the possible clinical management and prevention using systemic approaches. Curr Oncol (Toronto, Ont). 2023;30(5):4412\u201326. https:\/\/doi.org\/10.3390\/curroncol30050336.","journal-title":"Curr Oncol (Toronto, Ont)"},{"key":"2167_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/518261","volume":"2014","author":"EG Russi","year":"2014","unstructured":"Russi EG, Raber-Durlacher JE, Sonis ST. Local and systemic pathogenesis and consequences of regimen-induced inflammatory responses in patients with head and neck cancer receiving chemoradiation. Mediators Inflamm. 2014;2014: 518261. https:\/\/doi.org\/10.1155\/2014\/518261.","journal-title":"Mediators Inflamm"},{"key":"2167_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.949071","volume":"12","author":"I Klymiuk","year":"2022","unstructured":"Klymiuk I, Bilgilier C, Mahnert A, Prokesch A, Heininger C, Brandl I, et al. Chemotherapy-associated oral microbiome changes in breast cancer patients. Front Oncol. 2022;12: 949071. https:\/\/doi.org\/10.3389\/fonc.2022.949071.","journal-title":"Front Oncol"},{"key":"2167_CR32","unstructured":"Hosseini M-S, Sanaie S, Akbarzadeh MA, Fattahi S, Jabbari S. The potential impact of oral dysbiosis on the pathogenesis of oral neoplasms: a systematic review. Microb Interact Health Dis. 2024; 125."},{"issue":"12","key":"2167_CR33","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.clon.2019.06.011","volume":"31","author":"S Ghosh-Laskar","year":"2019","unstructured":"Ghosh-Laskar S, Pilar A, Prabhash K, Joshi A, Agarwal JP, Gupta T, et al. Taxane-based induction chemotherapy plus concurrent chemoradiotherapy in nasopharyngeal carcinoma: prospective results from a non-endemic cohort. Clin Oncol. 2019;31(12):850\u20137. https:\/\/doi.org\/10.1016\/j.clon.2019.06.011.","journal-title":"Clin Oncol"},{"issue":"14","key":"2167_CR34","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.3390\/cancers14143379","volume":"14","author":"J Stolze","year":"2022","unstructured":"Stolze J, Teepen JC, Raber-Durlacher JE, Loonen JJ, Kok JL, Tissing WJE, et al. Prevalence and risk factors for hyposalivation and xerostomia in childhood cancer survivors following different treatment modalities\u2014a dutch childhood cancer survivor study late effects 2 clinical study (DCCSS LATER 2). Cancers. 2022;14(14):3379. https:\/\/doi.org\/10.3390\/cancers14143379.","journal-title":"Cancers"},{"key":"2167_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.archoralbio.2019.06.003","volume":"105","author":"S Hitomi","year":"2019","unstructured":"Hitomi S, Ujihara I, Sago-Ito M, Nodai T, Shikayama T, Inenaga K, et al. Hyposalivation due to chemotherapy exacerbates oral ulcerative mucositis and delays its healing. Arch Oral Biol. 2019;105:20\u20136. https:\/\/doi.org\/10.1016\/j.archoralbio.2019.06.003.","journal-title":"Arch Oral Biol"},{"issue":"8","key":"2167_CR36","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1097\/MPH.0000000000000933","volume":"39","author":"A Al Mousa","year":"2017","unstructured":"Al Mousa A, Abu-Hijlih R, Salem A, Sultan I, Mula-Hussain L, Ismael T, et al. Induction methotrexate, cisplatin, and 5-fluorouracil versus cisplatin and 5-fluorouracil followed by radiotherapy in pediatric nasopharyngeal carcinoma: a retrospective analysis in a tertiary cancer center. J Pediatr Hematol\/Oncol. 2017;39(8):e437\u201342.","journal-title":"J Pediatr Hematol\/Oncol."},{"issue":"3","key":"2167_CR37","first-page":"475","volume":"15","author":"M Djuric","year":"2010","unstructured":"Djuric M, Cakic S, Hadzi-Mihailovic M, Petrovic D, Jankovic L. Oral status in patients receiving 5-fluorouracil for colorectal cancer. J BUON. 2010;15(3):475\u20139.","journal-title":"J BUON"},{"issue":"2","key":"2167_CR38","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/ph15020232","volume":"15","author":"WY Abdelzaher","year":"2022","unstructured":"Abdelzaher WY, Nassan MA, Ahmed SM, Welson NN, El-Saber BG, Khalaf HM. Xanthine oxidase inhibitor, febuxostat is effective against 5-fluorouracil-induced parotid salivary gland injury in rats via inhibition of oxidative stress, inflammation and targeting TRPC1\/CHOP signalling pathway. Pharmaceuticals. 2022;15(2):232.","journal-title":"Pharmaceuticals"},{"issue":"5\u20136","key":"2167_CR39","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.currproblcancer.2016.06.001","volume":"40","author":"A Villa","year":"2016","unstructured":"Villa A, Sonis S. Toxicities associated with head and neck cancer treatment and oncology-related clinical trials. Curr Probl Cancer. 2016;40(5\u20136):244\u201357.","journal-title":"Curr Probl Cancer"},{"issue":"12","key":"2167_CR40","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2146\/ajhp120467","volume":"70","author":"LJ Radvansky","year":"2013","unstructured":"Radvansky LJ, Pace MB, Siddiqui A. Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia. Am J Health-Syst Pharm. 2013;70(12):1025\u201332.","journal-title":"Am J Health-Syst Pharm."},{"key":"2167_CR41","doi-asserted-by":"publisher","first-page":"100177","DOI":"10.1016\/j.oor.2024.100177","volume":"10","author":"DM Abo El Fadel","year":"2024","unstructured":"Abo El Fadel DM, Kamal Y, Hassouna AH, Ali A. Prevalence of oral side effects associated with chemo and radiotherapy in head and neck cancer treatment: a cross-sectional study in Egypt. Oral Oncol Rep. 2024;10:100177. https:\/\/doi.org\/10.1016\/j.oor.2024.100177.","journal-title":"Oral Oncol Rep."},{"key":"2167_CR42","doi-asserted-by":"publisher","unstructured":"Hosseini M-S, Akbarzadeh MA, Jadidi-Niaragh F. Myeloid-derived suppressor cells and macrophage polarization in cancer immunotherapy. critical developments in cancer immunotherapy. IGI Global. 2024. p. 157\u2013204. https:\/\/doi.org\/10.4018\/979-8-3693-3976-3.ch005.","DOI":"10.4018\/979-8-3693-3976-3.ch005"},{"key":"2167_CR43","doi-asserted-by":"publisher","unstructured":"Klein BA, Shazib MA, Villa A, de Abreu AF, Vacharotayangul P, Sonis S, et al. Immune checkpoint inhibitors in cancer therapy: review of orofacial adverse events and role of the oral healthcare provider. Front Oral Health. 2022;3. https:\/\/doi.org\/10.3389\/froh.2022.968157.","DOI":"10.3389\/froh.2022.968157"},{"issue":"11","key":"2167_CR44","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1002\/cncr.33436","volume":"127","author":"Y Xu","year":"2021","unstructured":"Xu Y, Wen N, Sonis ST, Villa A. Oral side effects of immune checkpoint inhibitor therapy (ICIT): an analysis of 4683 patients receiving ICIT for malignancies at Massachusetts General Hospital, Brigham & Women\u2019s Hospital, and the Dana-Farber Cancer Institute, 2011 to 2019. Cancer. 2021;127(11):1796\u2013804. https:\/\/doi.org\/10.1002\/cncr.33436.","journal-title":"Cancer"},{"issue":"5","key":"2167_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2023.07.043","volume":"136","author":"OVO Filho","year":"2023","unstructured":"Filho OVO, Medeiros YDL, Oliveira TBD, Gibbons IL, Treister NS, Alves FA. Prevalence of cutaneous and oral immune-related adverse events related to immune checkpoint inhibitor therapy in a single institution. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023;136(5): e169. https:\/\/doi.org\/10.1016\/j.oooo.2023.07.043.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"46","key":"2167_CR46","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000031761","volume":"101","author":"X Zhang","year":"2022","unstructured":"Zhang X, Lu X, Yu Y, Tan K, Cui H. Changes of IL-6 And IFN-\u03b3 before and after the adverse events related to immune checkpoint inhibitors: a retrospective study. Medicine. 2022;101(46): e31761. https:\/\/doi.org\/10.1097\/md.0000000000031761.","journal-title":"Medicine"},{"key":"2167_CR47","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s11282-020-00480-9","volume":"37","author":"K Kouji","year":"2021","unstructured":"Kouji K, Saori F, Kayoko I, Kaname N, Noboru K, Masaki T, et al. Radiological imaging features of the salivary glands in xerostomia induced by an immune checkpoint inhibitor. Oral Radiol. 2021;37:531\u20136.","journal-title":"Oral Radiol"},{"issue":"9","key":"2167_CR48","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1634\/theoncologist.2018-0823","volume":"24","author":"BM Warner","year":"2019","unstructured":"Warner BM, Baer AN, Lipson EJ, Allen C, Hinrichs C, Rajan A, et al. Sicca syndrome associated with immune checkpoint inhibitor therapy. Oncologist. 2019;24(9):1259\u201369.","journal-title":"Oncologist"},{"key":"2167_CR49","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/978-3-030-79308-1_17","volume-title":"Immunotherapy","author":"N Al-Zubidi","year":"2021","unstructured":"Al-Zubidi N, Cody Page J, GombosDan S, Akanksha S, Eric A, Gidley PW, et al. Immune-related oral, otologic, and ocular adverse events. In: Immunotherapy. Cham: Springer; 2021. p. 399\u2013416."},{"issue":"6","key":"2167_CR50","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4103\/apjon.apjon-2136","volume":"8","author":"MF Asan","year":"2021","unstructured":"Asan MF, Castelino RL, Babu SG, Rao K, Pandita V. Oral immune-related adverse events\u2014current concepts and their management. Asia-Pac J Oncol Nurs. 2021;8(6):604\u20139. https:\/\/doi.org\/10.4103\/apjon.apjon-2136.","journal-title":"Asia-Pac J Oncol Nurs."},{"issue":"1","key":"2167_CR51","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3390\/cancers15010250","volume":"15","author":"A Ullah","year":"2022","unstructured":"Ullah A, Khan J, Waheed A, Karki NR, Goodbee M, Yasinzai AQK, et al. Mucoepidermoid carcinoma of the salivary gland: demographics and comparative analysis in us children and adults with future perspective of management. Cancers. 2022;15(1):250. https:\/\/doi.org\/10.3390\/cancers15010250.","journal-title":"Cancers"},{"key":"2167_CR52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ajo.2021.02.022","volume":"227","author":"P Marco","year":"2021","unstructured":"Marco P, Federico B, Francesco B, Mario A, Giuseppe G, Piera V, et al. Incidence, risk factors and complications of ocular graft-versus-host disease following hematopoietic stem cell transplantation. Am J Ophthalmol. 2021;227:25\u201334.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2167_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/idj.12584","volume":"71","author":"S Elad","year":"2021","unstructured":"Elad S, Aljitawi O, Zadik Y. Oral graft-versus-host disease: a pictorial review and a guide for dental practitioners. Int Dental J. 2021;71(1):9\u201320.","journal-title":"Int Dental J."},{"issue":"4","key":"2167_CR54","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/odi.12028","volume":"19","author":"JW Mays","year":"2013","unstructured":"Mays JW, Fassil H, Edwards DA, Pavletic SZ, Bassim CW. Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research. Oral Dis. 2013;19(4):327\u201346.","journal-title":"Oral Dis"},{"key":"2167_CR55","doi-asserted-by":"crossref","unstructured":"Cherry-Peppers G, Fryer C, Jackson AD, Ford D, Glascoe A, Smith D, et al. A review of the risks and relationships between oral health and chronic diseases. J Nat Med Assoc. 2024.","DOI":"10.1016\/j.jnma.2024.01.003"},{"issue":"5","key":"2167_CR56","first-page":"234","volume":"37","author":"S Marcott","year":"2020","unstructured":"Marcott S, Dewan K, Kwan M, Baik F, Lee YJ, Sirjani D. Where dysphagia begins: polypharmacy and xerostomia. Fed Practition. 2020;37(5):234\u201341.","journal-title":"Fed Practition"},{"issue":"2","key":"2167_CR57","first-page":"74","volume":"20","author":"MG Arakelyan","year":"2016","unstructured":"Arakelyan MG, Tambovtseva NV, Arzukanyan AV. The main causes and clinical manifestations of xerostomia. Russian J Dentis. 2016;20(2):74\u20138.","journal-title":"Russian J Dentis."},{"issue":"008","key":"2167_CR58","first-page":"1","volume":"1","author":"I Ristevska","year":"2015","unstructured":"Ristevska I, Armata RS, D\u2019Ambrosio C, Furtado M, Anand L, Katzman MA. Xerostomia: understanding the diagnosis and the treatment of dry mouth. J Fam Med Dis Prev. 2015;1(008):1\u20135.","journal-title":"J Fam Med Dis Prev"},{"key":"2167_CR59","first-page":"1","volume-title":"Interdisciplinary cancer research","author":"E Somay","year":"2024","unstructured":"Somay E, Topkan E, Bascil S, Selek U. Influence of radiation-induced xerostomia on tooth loss in head and neck cancer patients. In: Interdisciplinary cancer research. Cham: Springer International Publishing; 2024. p. 1\u201319."},{"issue":"1","key":"2167_CR60","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.oooo.2020.04.003","volume":"130","author":"NR Palmier","year":"2020","unstructured":"Palmier NR, Migliorati CA, Prado-Ribeiro AC, de Oliveira MCQ, Vechiato FAJ, de Goes MF, et al. Radiation-related caries: current diagnostic, prognostic, and management paradigms. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;130(1):52\u201362. https:\/\/doi.org\/10.1016\/j.oooo.2020.04.003.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2167_CR61","unstructured":"Health US Department of, Services Human. Common terminology criteria for adverse events (CTCAE). (No Title). 2010."},{"issue":"7","key":"2167_CR62","doi-asserted-by":"publisher","first-page":"CD012744","DOI":"10.1002\/14651858.cd012744","volume":"7","author":"P Riley","year":"2017","unstructured":"Riley P, Glenny AM, Hua F, Worthington HV. Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy. Cochrane Database Syst Rev. 2017;7(7):CD012744. https:\/\/doi.org\/10.1002\/14651858.cd012744.","journal-title":"Cochrane Database Syst Rev"},{"key":"2167_CR63","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.oraloncology.2016.12.031","volume":"66","author":"V Mercadante","year":"2017","unstructured":"Mercadante V, Al Hamad A, Lodi G, Porter S, Fedele S. Interventions for the management of radiotherapy-induced xerostomia and hyposalivation: A systematic review and meta-analysis. Oral Oncol. 2017;66:64\u201374. https:\/\/doi.org\/10.1016\/j.oraloncology.2016.12.031.","journal-title":"Oral Oncol"},{"issue":"5","key":"2167_CR64","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1124\/mol.117.109678","volume":"92","author":"AN Pronin","year":"2017","unstructured":"Pronin AN, Wang Q, Slepak VZ. Teaching an old drug new tricks: agonism, antagonism, and biased signaling of pilocarpine through M3 muscarinic acetylcholine receptor. Mol Pharmacol. 2017;92(5):601\u201312. https:\/\/doi.org\/10.1124\/mol.117.109678.","journal-title":"Mol Pharmacol"},{"key":"2167_CR65","volume-title":"Muscarinic agonists","author":"T Bui","year":"2024","unstructured":"Bui T, Duong H. Muscarinic agonists. StatPearls: StatPearls Publishing; 2024."},{"issue":"16","key":"2167_CR66","doi-asserted-by":"publisher","first-page":"8908","DOI":"10.3390\/ijms22168908","volume":"22","author":"P Oleksak","year":"2021","unstructured":"Oleksak P, Novotny M, Patocka J, Nepovimova E, Hort J, Pavlik J, et al. Neuropharmacology of cevimeline and muscarinic drugs-focus on cognition and neurodegeneration. Int J Mol Sci. 2021;22(16):8908. https:\/\/doi.org\/10.3390\/ijms22168908.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2167_CR67","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/ph15060762","volume":"15","author":"A Kapourani","year":"2022","unstructured":"Kapourani A, Kontogiannopoulos KN, Barmpalexis P. A review on the role of pilocarpine on the management of xerostomia and the importance of the topical administration systems development. Pharmaceuticals (Basel, Switzerland). 2022;15(6):762. https:\/\/doi.org\/10.3390\/ph15060762.","journal-title":"Pharmaceuticals (Basel, Switzerland)."},{"issue":"2","key":"2167_CR68","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1601-5037.2008.00326.x","volume":"7","author":"MA Braga","year":"2009","unstructured":"Braga MA, Tarzia O, Bergamaschi CC, Santos FA, Andrade ED, Groppo FC. Comparison of the effects of pilocarpine and cevimeline on salivary flow. Int J Dental Hyg. 2009;7(2):126\u201330. https:\/\/doi.org\/10.1111\/j.1601-5037.2008.00326.x.","journal-title":"Int J Dental Hyg"},{"issue":"8","key":"2167_CR69","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1111\/odi.13192","volume":"25","author":"AM Farag","year":"2019","unstructured":"Farag AM, Holliday C, Cimmino J, Roomian T, Papas A. Comparing the effectiveness and adverse effects of pilocarpine and cevimeline in patients with hyposalivation. Oral Dis. 2019;25(8):1937\u201344. https:\/\/doi.org\/10.1111\/odi.13192.","journal-title":"Oral Dis"},{"issue":"3","key":"2167_CR70","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/scd.12010","volume":"33","author":"J Brimhall","year":"2013","unstructured":"Brimhall J, Jhaveri MA, Yepes JF. Efficacy of cevimeline vs. pilocarpine in the secretion of saliva: a pilot study. Special Care Dentis. 2013;33(3):123\u20137.","journal-title":"Special Care Dentis."},{"key":"2167_CR71","unstructured":"Estafanos R. Extemporaneously compounded buccal pilocarpine preparations, acceptability and pilot testing for the treatment of xerostomia (dry mouth) in Australia. 2020."},{"issue":"1","key":"2167_CR72","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12903-022-02576-6","volume":"22","author":"B Motamed","year":"2022","unstructured":"Motamed B, Alaee A, Azizi A, Jahandar H, Fard MJK, Jafari A. Comparison of the 1 and 2% pilocarpine mouthwash in a xerostomic population: a randomized clinical trial. BMC Oral Health. 2022;22(1):548. https:\/\/doi.org\/10.1186\/s12903-022-02576-6.","journal-title":"BMC Oral Health"},{"issue":"3","key":"2167_CR73","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/joor.12127","volume":"41","author":"JH Kim","year":"2014","unstructured":"Kim JH, Ahn H-J, Choi J-H, Jung DW, Kwon J-S. Effect of 0.1% pilocarpine mouthwash on xerostomia: double-blind, randomised controlled trial. J Oral Rehabil. 2014;41(3):226\u201335. https:\/\/doi.org\/10.1111\/joor.12127.","journal-title":"J Oral Rehabil"},{"key":"2167_CR74","doi-asserted-by":"publisher","first-page":"104324","DOI":"10.1016\/j.yexmp.2019.104324","volume":"112","author":"H Eren","year":"2020","unstructured":"Eren H, Mercantepe T, Tumkaya L, Mercantepe F, Dil E, Horsanali MO, et al. Evaluation of the protective effects of amifostine and melatonin against cisplatin induced testis injury via oxidative stress and apoptosis in rats. Exp Mol Pathol. 2020;112:104324.","journal-title":"Exp Mol Pathol"},{"issue":"7","key":"2167_CR75","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/14737159.2021.1933448","volume":"21","author":"VK Singh","year":"2021","unstructured":"Singh VK, Seed TM, Cheema AK. Metabolomics-based predictive biomarkers of radiation injury and countermeasure efficacy: current status and future perspectives. Exp Rev Mol Diagn. 2021;21(7):641\u201354.","journal-title":"Exp Rev Mol Diagn."},{"issue":"6","key":"2167_CR76","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1634\/theoncologist.12-6-738","volume":"12","author":"JR Kouvaris","year":"2007","unstructured":"Kouvaris JR, Kouloulias VE, Vlahos LJ. Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist. 2007;12(6):738\u201347. https:\/\/doi.org\/10.1634\/theoncologist.12-6-738.","journal-title":"Oncologist"},{"key":"2167_CR77","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3389\/fphar.2018.00394","volume":"9","author":"A Arora","year":"2018","unstructured":"Arora A, Bhuria V, Hazari PP, Pathak U, Mathur S, Roy BG, et al. Amifostine analog, DRDE-30, attenuates bleomycin-induced pulmonary fibrosis in mice. Front Pharmacol. 2018;9:394. https:\/\/doi.org\/10.3389\/fphar.2018.00394.","journal-title":"Front Pharmacol"},{"issue":"5","key":"2167_CR78","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2165\/00003495-200161050-00012","volume":"61","author":"CR Culy","year":"2001","unstructured":"Culy CR, Spencer CM. Amifostine: an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome. Drugs. 2001;61(5):641\u201384. https:\/\/doi.org\/10.2165\/00003495-200161050-00012.","journal-title":"Drugs"},{"issue":"Suppl 124","key":"2167_CR79","first-page":"237","volume":"38","author":"R Priori","year":"2020","unstructured":"Priori R, Mastromanno L, Izzo R. What about glucocorticoids in primary Sj\u00f6gren\u2019s syndrome? Clin Exp Rheumatol. 2020;38(Suppl 124):237\u201344.","journal-title":"Clin Exp Rheumatol"},{"issue":"2\u20133","key":"2167_CR80","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ejphar.2007.12.033","volume":"583","author":"R Malcher-Lopes","year":"2008","unstructured":"Malcher-Lopes R, Franco A, Tasker JG. Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch. Eur J Pharmacol. 2008;583(2\u20133):322\u201339. https:\/\/doi.org\/10.1016\/j.ejphar.2007.12.033.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2167_CR81","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s00520-021-06535-9","volume":"30","author":"H Bustillos","year":"2022","unstructured":"Bustillos H, Indorf A, Alwan L, Thompson J, Jung L. Xerostomia: an immunotherapy-related adverse effect in cancer patients. Support Care Cancer. 2022;30(2):1681\u20137. https:\/\/doi.org\/10.1007\/s00520-021-06535-9.","journal-title":"Support Care Cancer"},{"issue":"3","key":"2167_CR82","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-4632.2009.04322.x","volume":"49","author":"S Moghadam-Kia","year":"2010","unstructured":"Moghadam-Kia S, Werth VP. Prevention and treatment of systemic glucocorticoid side effects. Int J Dermatol. 2010;49(3):239\u201348. https:\/\/doi.org\/10.1111\/j.1365-4632.2009.04322.x.","journal-title":"Int J Dermatol"},{"key":"2167_CR83","doi-asserted-by":"publisher","first-page":"103826","DOI":"10.1016\/j.critrevonc.2022.103826","volume":"180","author":"A Faggiano","year":"2022","unstructured":"Faggiano A, Mazzilli R, Natalicchio A, Adinolfi V, Argentiero A, Danesi R, et al. Corticosteroids in oncology: use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)\/ Italian Association of Medical Diabetologists (AMD)\/ Italian Society of Endocrinology (SIE)\/Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper. Crit Rev Oncol\/Hematol. 2022;180:103826. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103826.","journal-title":"Crit Rev Oncol\/Hematol."},{"issue":"6","key":"2167_CR84","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1083\/jcb.201708007","volume":"217","author":"Y Wang","year":"2018","unstructured":"Wang Y, Branicky R, No\u00eb A, Hekimi S. Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signaling. J Cell Biol. 2018;217(6):1915\u201328. https:\/\/doi.org\/10.1083\/jcb.201708007.","journal-title":"J Cell Biol"},{"key":"2167_CR85","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2147\/dddt.s267400","volume":"15","author":"ST Sonis","year":"2021","unstructured":"Sonis ST. Superoxide dismutase as an intervention for radiation therapy-associated toxicities: review and profile of avasopasem manganese as a treatment option for radiation-induced mucositis. Drug Des Dev Ther. 2021;15:1021\u20139. https:\/\/doi.org\/10.2147\/dddt.s267400.","journal-title":"Drug Des Dev Ther"},{"issue":"593","key":"2167_CR86","doi-asserted-by":"publisher","first-page":"eabb3788","DOI":"10.1126\/scitranslmed.abb3768","volume":"13","author":"BJ Sishc","year":"2021","unstructured":"Sishc BJ, Ding L, Nam TK, Heer CD, Rodman SN, Schoenfeld JD, et al. Avasopasem manganese synergizes with hypofractionated radiation to ablate tumors through the generation of hydrogen peroxide. Sci Transl Med. 2021;13(593):eabb3788. https:\/\/doi.org\/10.1126\/scitranslmed.abb3768.","journal-title":"Sci Transl Med."},{"key":"2167_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101542","volume":"34","author":"A Chatterjee","year":"2020","unstructured":"Chatterjee A, Kosmacek EA, Shrishrimal S, McDonald JT, Oberley-Deegan RE. MnTE-2-PyP, a manganese porphyrin, reduces cytotoxicity caused by irradiation in a diabetic environment through the induction of endogenous antioxidant defenses. Redox Biol. 2020;34: 101542. https:\/\/doi.org\/10.1016\/j.redox.2020.101542.","journal-title":"Redox Biol"},{"key":"2167_CR88","doi-asserted-by":"crossref","unstructured":"Pinna R, Campus G, Cumbo E, Mura I, Milia E. Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage. Therapeut Clin Risk Manage. 2015:171\u201388.","DOI":"10.2147\/TCRM.S70652"},{"issue":"5","key":"2167_CR89","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/stcltm\/szac011","volume":"11","author":"CD Lynggaard","year":"2022","unstructured":"Lynggaard CD, Gr\u00f8nh\u00f8j C, Christensen R, Fischer-Nielsen A, Melchiors J, Specht L, et al. Intraglandular off-the-shelf allogeneic mesenchymal stem cell treatment in patients with radiation-induced xerostomia: a safety study (MESRIX-II). Stem Cells Transl Med. 2022;11(5):478\u201389. https:\/\/doi.org\/10.1093\/stcltm\/szac011.","journal-title":"Stem Cells Transl Med"},{"issue":"11","key":"2167_CR90","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jcyt.2023.07.009","volume":"25","author":"GC Blitzer","year":"2023","unstructured":"Blitzer GC, Glazer T, Burr A, Gustafson S, Ganz O, Meyers R, et al. Marrow-derived autologous stromal cells for the restoration of salivary hypofunction (MARSH): a pilot, first-in-human study of interferon gamma-stimulated marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia. Cytotherapy. 2023;25(11):1139\u201344. https:\/\/doi.org\/10.1016\/j.jcyt.2023.07.009.","journal-title":"Cytotherapy"},{"issue":"11","key":"2167_CR91","first-page":"1","volume":"5","author":"CG Awuchi","year":"2019","unstructured":"Awuchi CG, Echeta KC. Current developments in sugar alcohols: chemistry, nutrition, and health concerns of sorbitol, xylitol, glycerol, arabitol, inositol, maltitol, and lactitol. Int J Adv Acad Res. 2019;5(11):1\u201333.","journal-title":"Int J Adv Acad Res."},{"issue":"6","key":"2167_CR92","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1875-595X.2011.00064.x","volume":"61","author":"JB Taheri","year":"2011","unstructured":"Taheri JB, Azimi S, Rafieian N, Zanjani HA. Herbs in dentistry. Int Dental J. 2011;61(6):287\u201396.","journal-title":"Int Dental J."},{"key":"2167_CR93","unstructured":"Agung I, Wedagama DM. Angular cheilitis: malnutrition, diet and home remedies in children. Lambert Academic Publishing. 2019."},{"issue":"5","key":"2167_CR94","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/polym14050850","volume":"14","author":"A Kapourani","year":"2022","unstructured":"Kapourani A, Kontogiannopoulos KN, Manioudaki A-E, Poulopoulos AK, Tsalikis L, Assimopoulou AN, et al. A review on xerostomia and its various management strategies: the role of advanced polymeric materials in the treatment approaches. Polymers. 2022;14(5):850.","journal-title":"Polymers"},{"issue":"2","key":"2167_CR95","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/jtxs.12575","volume":"52","author":"J Hu","year":"2021","unstructured":"Hu J, Andablo-Reyes E, Mighell A, Pavitt S, Sarkar A. Dry mouth diagnosis and saliva substitutes\u2014a review from a textural perspective. J Texture Stud. 2021;52(2):141\u201356.","journal-title":"J Texture Stud"},{"issue":"8","key":"2167_CR96","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3390\/ph16081136","volume":"16","author":"KN Kontogiannopoulos","year":"2023","unstructured":"Kontogiannopoulos KN, Kapourani A, Gkougkourelas I, Anagnostaki M-E, Tsalikis L, Assimopoulou AN, et al. A review of the role of natural products as treatment approaches for xerostomia. Pharmaceuticals. 2023;16(8):1136.","journal-title":"Pharmaceuticals"},{"issue":"5","key":"2167_CR97","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00432-022-04200-0","volume":"149","author":"M-L Ritschel","year":"2023","unstructured":"Ritschel M-L, H\u00fcbner J, Wurm-Kuczera R, B\u00fcntzel J. Phytotherapy known and applied by head-neck cancer patients and medical students to treat oral discomfort in Germany: an observational study. J Cancer Res Clin Oncol. 2023;149(5):2057\u201370. https:\/\/doi.org\/10.1007\/s00432-022-04200-0.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2167_CR98","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1038\/s41598-017-03272-0","volume":"7","author":"MWC Chan","year":"2017","unstructured":"Chan MWC, Wu XY, Wu JCY, Wong SYS, Chung VCH. Safety of acupuncture: overview of systematic reviews. Sci Rep. 2017;7(1):3369.","journal-title":"Sci Rep"},{"issue":"3","key":"2167_CR99","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/1534735412451321","volume":"12","author":"L Zhuang","year":"2013","unstructured":"Zhuang L, Yang Z, Zeng X, Zhua X, Chen Z, Liu L, et al. The preventive and therapeutic effect of acupuncture for radiation-induced xerostomia in patients with head and neck cancer: a systematic review. Integr Cancer Thera. 2013;12(3):197\u2013205.","journal-title":"Integr Cancer Thera."},{"issue":"5","key":"2167_CR100","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.oooo.2014.01.229","volume":"117","author":"TL Lovelace","year":"2014","unstructured":"Lovelace TL, Fox NF, Sood AJ, Nguyen SA, Day TA. Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(5):595\u2013607.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2167_CR101","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/med\/9780199543588.003.0021","volume-title":"Oral complications of cancer and its management","author":"A Davies","year":"2010","unstructured":"Davies A. Salivary gland dysfunction. In: Oral complications of cancer and its management. Oxford: Oxford University Press; 2010. p. 203\u201323."},{"issue":"6","key":"2167_CR102","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.21873\/invivo.12993","volume":"36","author":"J Hubner","year":"2022","unstructured":"Hubner J, Dorfler J, Freuding M, Zaiser C, Buntzel J, Keinki C, et al. Methodological review: summary of findings for acupuncture as treatment for cancer therapy-induced xerostomia. In vivo (Athens, Greece). 2022;36(6):2579\u201397. https:\/\/doi.org\/10.21873\/invivo.12993.","journal-title":"In vivo (Athens, Greece)"},{"issue":"4","key":"2167_CR103","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/hed.27297","volume":"45","author":"J D\u00f6rfler","year":"2023","unstructured":"D\u00f6rfler J, Freuding M, Zaiser C, B\u00fcntzel J, Keinki C, K\u00e4smann L, et al. Umbrella review: summary of findings for acupuncture as treatment for radiation-induced xerostomia. Head Neck. 2023;45(4):1026\u201344. https:\/\/doi.org\/10.1002\/hed.27297.","journal-title":"Head Neck"},{"issue":"3","key":"2167_CR104","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3390\/antiox12030704","volume":"12","author":"P Marino","year":"2023","unstructured":"Marino P, Pepe G, Basilicata MG, Vestuto V, Marzocco S, Autore G, et al. Potential role of natural antioxidant products in oncological diseases. Antioxidants. 2023;12(3):704.","journal-title":"Antioxidants"},{"issue":"20","key":"2167_CR105","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.3390\/nu14204329","volume":"14","author":"D Jennifer","year":"2022","unstructured":"Jennifer D, Amanda A, Hui-Ling Y, Kate D, Wasek F. Vitamin E in cancer treatment: a review of clinical applications in randomized control trials. Nutrients. 2022;14(20):4329.","journal-title":"Nutrients"},{"issue":"12","key":"2167_CR106","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.3390\/nu13124235","volume":"13","author":"S Indre","year":"2021","unstructured":"Indre S, Jolanta A, Alina P, Lina S-M. Association between diet and xerostomia: is xerostomia a barrier to a healthy eating pattern? Nutrients. 2021;13(12):4235.","journal-title":"Nutrients"},{"issue":"14","key":"2167_CR107","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.3390\/jcm12144592","volume":"12","author":"F M\u00fcller","year":"2023","unstructured":"M\u00fcller F, Chebib N, Maniewicz S, Genton L. The impact of xerostomia on food choices\u2014a review with clinical recommendations. J Clin Med. 2023;12(14):4592.","journal-title":"J Clin Med"},{"issue":"3","key":"2167_CR108","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1742-1241.2009.02132.x","volume":"64","author":"V Visvanathan","year":"2010","unstructured":"Visvanathan V, Nix P. Managing the patient presenting with xerostomia: a review. Int J Clin Pract. 2010;64(3):404\u20137.","journal-title":"Int J Clin Pract"},{"issue":"5","key":"2167_CR109","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/odi.13648","volume":"27","author":"N Galiano-Castillo","year":"2021","unstructured":"Galiano-Castillo N, Liu L, Lozano-Lozano M, Tumilty S, Cantarero-Villanueva I, Baxter GD. Acute and cumulative benefits of photobiomodulation for xerostomia: a systematic review and meta-analysis. Oral Dis. 2021;27(5):1115\u201326.","journal-title":"Oral Dis"},{"issue":"6","key":"2167_CR110","first-page":"340","volume":"38","author":"V Heiskanen","year":"2020","unstructured":"Heiskanen V, Zadik Y, Elad S. Photobiomodulation therapy for cancer treatment-related salivary gland dysfunction: a systematic review. Photobiomodul Photomed Laser Surg. 2020;38(6):340\u20137.","journal-title":"Photobiomodul Photomed Laser Surg."},{"key":"2167_CR111","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1007\/s00405-023-08425-8","volume":"281","author":"SV Oliveira","year":"2024","unstructured":"Oliveira SV, Batista JVF, Gutierres GG, Silva NP, Lino-dos-Santos-Franco A, Rodrigues MFSD, et al. The supportive use of photobiomodulation on salivary glands: a narrative review and meta-analysis. Eur Arch Oto-Rhino-Laryngol. 2024;281:2793.","journal-title":"Eur Arch Oto-Rhino-Laryngol."},{"issue":"3","key":"2167_CR112","doi-asserted-by":"publisher","first-page":"e9512338070","DOI":"10.33448\/rsd-v12i3.38070","volume":"12","author":"LCA de Lima","year":"2023","unstructured":"de Lima LCA, Guimar\u00e3es DM, ESilva ES, Do Couto MFN, Oliveira GL, Alves MSA, et al. Photobiomodulation in the treatment of oral diseases. Res Soc Dev. 2023;12(3):e9512338070.","journal-title":"Res Soc Dev."},{"key":"2167_CR113","first-page":"173","volume-title":"Lasers in dentistry\u2014current concepts","author":"M Cronshaw","year":"2024","unstructured":"Cronshaw M, Mylona V. photobiomodulation therapy within clinical dentistry: theoretical and applied concepts. In: Lasers in dentistry\u2014current concepts. Cham: Springer; 2024. p. 173\u2013236."},{"issue":"2","key":"2167_CR114","doi-asserted-by":"publisher","first-page":"767","DOI":"10.4103\/jfmpc.jfmpc_922_21","volume":"11","author":"R Chandra","year":"2022","unstructured":"Chandra R, Bhakta P, Beniwal J, Dhanda R, Saxena V, Sinha S. Evaluation of the efficacy of transcutaneous electrical nerve stimulation (TENS) on salivary flow rate in patients with xerostomia\u2014a case control study. J Fam Med Prim Care. 2022;11(2):767\u201371. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_922_21.","journal-title":"J Fam Med Prim Care"},{"issue":"1","key":"2167_CR115","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.4317\/jced.51828","volume":"7","author":"H Aggarwal","year":"2015","unstructured":"Aggarwal H, Pal-Singh M, Mathur H, Astekar S, Gulati P, Lakhani S. Evaluation of the effect of transcutaneous electrical nerve stimulation (TENS) on whole salivary flow rate. J Clin Exp Dent. 2015;7(1):e13\u20137. https:\/\/doi.org\/10.4317\/jced.51828.","journal-title":"J Clin Exp Dent"},{"key":"2167_CR116","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.amsu.2021.01.094","volume":"63","author":"F Salimi","year":"2021","unstructured":"Salimi F, Saavedra F, Andrews B, FitzGerald J, Winter SC. Trans-cutaneous electrical nerve stimulation to treat dry mouth (xerostomia) following radiotherapy for head and neck cancer. A systematic review. Ann Med Surg. 2021;63:102146. https:\/\/doi.org\/10.1016\/j.amsu.2021.01.094.","journal-title":"Ann Med Surg."},{"issue":"1","key":"2167_CR117","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2045-9912-3-15","volume":"3","author":"T Hadley","year":"2013","unstructured":"Hadley T, Song C, Wells L, Lehnhardt J, Rogers MW, Anderson J, et al. Does hyperbaric oxygen therapy have the potential to improve salivary gland function in irradiated head and neck cancer patients? Med Gas Res. 2013;3(1):15. https:\/\/doi.org\/10.1186\/2045-9912-3-15.","journal-title":"Med Gas Res"},{"issue":"1","key":"2167_CR118","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.oooo.2015.03.007","volume":"120","author":"NF Fox","year":"2015","unstructured":"Fox NF, Xiao C, Sood AJ, Lovelace TL, Nguyen SA, Sharma A, et al. Hyperbaric oxygen therapy for the treatment of radiation-induced xerostomia: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(1):22\u20138. https:\/\/doi.org\/10.1016\/j.oooo.2015.03.007.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"6","key":"2167_CR119","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/1754-9485.12789","volume":"62","author":"S Sherlock","year":"2018","unstructured":"Sherlock S, Way M, Tabah A. Hyperbaric oxygen treatment for the management of radiation-induced xerostomia. J Med Imaging Radiat Oncol. 2018;62(6):841\u20136. https:\/\/doi.org\/10.1111\/1754-9485.12789.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"3","key":"2167_CR120","doi-asserted-by":"publisher","first-page":"811","DOI":"10.18311\/jnr\/2023\/31848","volume":"23","author":"BR Premalatha","year":"2023","unstructured":"Premalatha BR, Ravindra S, Hegde U, Chandavarkar V, Mishra MN, Sangeetha R. AYUSH in oral health and diseases: an overview. J Nat Remedies. 2023;23(3):811\u201323. https:\/\/doi.org\/10.18311\/jnr\/2023\/31848.","journal-title":"J Nat Remedies."},{"issue":"3","key":"2167_CR121","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.homp.2005.03.002","volume":"94","author":"S Haila","year":"2005","unstructured":"Haila S, Koskinen A, Tenovuo J. Effects of homeopathic treatment on salivary flow rate and subjective symptoms in patients with oral dryness: a randomized trial. Homeopathy J Faculty Homeopathy. 2005;94(3):175\u201381. https:\/\/doi.org\/10.1016\/j.homp.2005.03.002.","journal-title":"Homeopathy J Faculty Homeopathy"},{"issue":"5","key":"2167_CR122","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s00432-022-04054-6","volume":"149","author":"W Anna","year":"2023","unstructured":"Anna W, Jennifer D, Maren F, Lena J, Jutta H. Homeopathy effects in patients during oncological treatment: a systematic review. J Cancer Res Clin Oncol. 2023;149(5):1785\u2013810. https:\/\/doi.org\/10.1007\/s00432-022-04054-6.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2167_CR123","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1748-717X-9-62","volume":"9","author":"Z Xiangmin","year":"2014","unstructured":"Xiangmin Z, Folin L, Lan Xiaolin Yu, Wei LW, Xiuhong Wu, et al. Clinical observation of submandibular gland transfer for the prevention of xerostomia after radiotherapy for nasopharyngeal carcinoma: a prospective randomized controlled study of 32 cases. Radiat Oncol. 2014;9(1):62. https:\/\/doi.org\/10.1186\/1748-717X-9-62.","journal-title":"Radiat Oncol"},{"issue":"2","key":"2167_CR124","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1001\/archotol.131.2.140","volume":"131","author":"R Jana","year":"2005","unstructured":"Jana R, Hadi S, Naresh J, Jeffrey H, David W, Richard L, et al. Submandibular gland transfer for prevention of xerostomia after radiation therapy: swallowing outcomes. Arch Otolaryngol Head Neck Surg. 2005;131(2):140\u20135. https:\/\/doi.org\/10.1001\/archotol.131.2.140.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"2167_CR125","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mehy.2009.08.022","volume":"74","author":"J Kolahi","year":"2010","unstructured":"Kolahi J, Mansourian M. Autotransplantation of cryopreserved minor salivary glands: A new approach for management of radiation-induced xerostomia. Med Hypotheses. 2010;74(1):29\u201330. https:\/\/doi.org\/10.1016\/j.mehy.2009.08.022.","journal-title":"Med Hypotheses"},{"issue":"4","key":"2167_CR126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002063","volume":"3","author":"IM Lombaert","year":"2008","unstructured":"Lombaert IM, Brunsting JF, Wierenga PK, Faber H, Stokman MA, Kok T, et al. Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS ONE. 2008;3(4): e2063. https:\/\/doi.org\/10.1371\/journal.pone.0002063.","journal-title":"PLoS ONE"},{"issue":"9","key":"2167_CR127","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1002\/hed.27449","volume":"45","author":"CA Nieri","year":"2023","unstructured":"Nieri CA, Benaim EH, Zhang YH, Garcia-Godoy F, Herr MJ, Zhang W, et al. Botox for the prevention of radiation-induced Sialadenitis and xerostomia in head and neck cancer patients: a pilot study. Head Neck. 2023;45(9):2198\u2013206. https:\/\/doi.org\/10.1002\/hed.27449.","journal-title":"Head Neck"},{"key":"2167_CR128","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.radonc.2021.03.036","volume":"160","author":"J Cao","year":"2021","unstructured":"Cao J, Zhang X, Jiang B, Chen J, Wang X, Wang L, et al. Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia. Radiothera Oncol. 2021;160:32\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2021.03.036.","journal-title":"Radiothera Oncol"},{"issue":"3","key":"2167_CR129","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.21037\/apm.2020.02.36","volume":"9","author":"JW Snider","year":"2020","unstructured":"Snider JW, Paine CC. Sticky stuff: xerostomia in patients undergoing head and neck radiotherapy\u2014prevalence, prevention, and palliative care. Ann Palliative Med. 2020;9(3):1340\u201350.","journal-title":"Ann Palliative Med."},{"issue":"8","key":"2167_CR130","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1001\/jamaoncol.2023.1352","volume":"9","author":"J Castelli","year":"2023","unstructured":"Castelli J, Thariat J, Benezery K, Hasbini A, Gery B, Berger A, et al. Weekly adaptive radiotherapy vs standard intensity-modulated radiotherapy for improving salivary function in patients with head and neck cancer: a phase 3 randomized clinical trial. JAMA Oncol. 2023;9(8):1056\u201364. https:\/\/doi.org\/10.1001\/jamaoncol.2023.1352.","journal-title":"JAMA Oncol"},{"issue":"3","key":"2167_CR131","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/acm2.12327","volume":"19","author":"J Lou","year":"2018","unstructured":"Lou J, Huang P, Ma C, Zheng Y, Chen J, Liang Y, et al. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma. J Appl Clin Med Phys. 2018;19(3):251\u201360. https:\/\/doi.org\/10.1002\/acm2.12327.","journal-title":"J Appl Clin Med Phys"},{"issue":"5","key":"2167_CR132","doi-asserted-by":"publisher","first-page":"455","DOI":"10.11607\/ijp.4499","volume":"29","author":"P Mall","year":"2016","unstructured":"Mall P, Chand P, Singh BP, Rao J, Siddarth R, Srivastava K. Effectiveness of positioning stents in radiation-induced xerostomia in patients with tongue carcinoma: a randomized controlled trial. Int J Prosthodont. 2016;29(5):455\u201360. https:\/\/doi.org\/10.11607\/ijp.4499.","journal-title":"Int J Prosthodont"},{"issue":"1","key":"2167_CR133","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13014-020-01536-0","volume":"15","author":"D Chen","year":"2020","unstructured":"Chen D, Chen X, Chen X, Jiang N, Jiang L. The efficacy of positioning stents in preventing oral complications after head and neck radiotherapy: a systematic literature review. Radiat Oncol (London, England). 2020;15(1):90. https:\/\/doi.org\/10.1186\/s13014-020-01536-0.","journal-title":"Radiat Oncol (London, England)"},{"issue":"12","key":"2167_CR134","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.16910","volume":"2","author":"MK Garcia","year":"2019","unstructured":"Garcia MK, Meng Z, Rosenthal DI, Shen Y, Chambers M, Yang P, et al. Effect of true and sham acupuncture on radiation-induced xerostomia among patients with head and neck cancer: a randomized clinical trial. JAMA Netw Open. 2019;2(12): e1916910. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.16910.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2167_CR135","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/annonc\/mds515","volume":"24","author":"R Simcock","year":"2013","unstructured":"Simcock R, Fallowfield L, Monson K, Solis-Trapala I, Parlour L, Langridge C, et al. ARIX: a randomised trial of acupuncture v oral care sessions in patients with chronic xerostomia following treatment of head and neck cancer. Ann Oncol. 2013;24(3):776\u201383. https:\/\/doi.org\/10.1093\/annonc\/mds515.","journal-title":"Ann Oncol"},{"issue":"13","key":"2167_CR136","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1002\/cncr.26550","volume":"118","author":"Z Meng","year":"2012","unstructured":"Meng Z, Garcia MK, Hu C, Chiang J, Chambers M, Rosenthal DI, et al. Randomized controlled trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma. Cancer. 2012;118(13):3337\u201344. https:\/\/doi.org\/10.1002\/cncr.26550.","journal-title":"Cancer"},{"issue":"6","key":"2167_CR137","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.oraloncology.2011.03.021","volume":"47","author":"L Forner","year":"2011","unstructured":"Forner L, Hyldegaard O, von Brockdorff AS, Specht L, Andersen E, Jansen EC, et al. Does hyperbaric oxygen treatment have the potential to increase salivary flow rate and reduce xerostomia in previously irradiated head and neck cancer patients? A pilot study. Oral Oncol. 2011;47(6):546\u201351. https:\/\/doi.org\/10.1016\/j.oraloncology.2011.03.021.","journal-title":"Oral Oncol"},{"issue":"4","key":"2167_CR138","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10103-017-2180-3","volume":"32","author":"LF Palma","year":"2017","unstructured":"Palma LF, Gonnelli FAS, Marcucci M, Dias RS, Giordani AJ, Segreto RA, et al. Impact of low-level laser therapy on hyposalivation, salivary pH, and quality of life in head and neck cancer patients post-radiotherapy. Lasers Med Sci. 2017;32(4):827\u201332. https:\/\/doi.org\/10.1007\/s10103-017-2180-3.","journal-title":"Lasers Med Sci"},{"key":"2167_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2020.111933","volume":"209","author":"GC Louzeiro","year":"2020","unstructured":"Louzeiro GC, Cherubini K, de Figueiredo MAZ, Salum FG. Effect of photobiomodulation on salivary flow and composition, xerostomia and quality of life of patients during head and neck radiotherapy in short term follow-up: a randomized controlled clinical trial. J Photochem Photobiol, B. 2020;209: 111933. https:\/\/doi.org\/10.1016\/j.jphotobiol.2020.111933.","journal-title":"J Photochem Photobiol, B"},{"issue":"1","key":"2167_CR140","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10103-023-03760-y","volume":"38","author":"RM de Carvalho e Silva","year":"2023","unstructured":"de Carvalho e Silva RM, Mendes FM, Degasperi GR, Pinheiro SL. Photobiomodulation for the management of xerostomia and oral mucositis in patients with cancer: a randomized clinical trial. Lasers Med Sci. 2023;38(1):101. https:\/\/doi.org\/10.1007\/s10103-023-03760-y.","journal-title":"Lasers Med Sci"},{"issue":"6","key":"2167_CR141","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1007\/s00520-019-05132-1","volume":"28","author":"S Nuchit","year":"2020","unstructured":"Nuchit S, Lam-Ubol A, Paemuang W, Talungchit S, Chokchaitam O, Mungkung OO, et al. Alleviation of dry mouth by saliva substitutes improved swallowing ability and clinical nutritional status of post-radiotherapy head and neck cancer patients: a randomized controlled trial. Support Care Cancer. 2020;28(6):2817\u201328. https:\/\/doi.org\/10.1007\/s00520-019-05132-1.","journal-title":"Support Care Cancer"},{"issue":"11","key":"2167_CR142","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/joor.12545","volume":"44","author":"O Apperley","year":"2017","unstructured":"Apperley O, Medlicott N, Rich A, Hanning S, Huckabee ML. A clinical trial of a novel emulsion for potential use as a saliva substitute in patients with radiation-induced xerostomia. J Oral Rehabil. 2017;44(11):889\u201395. https:\/\/doi.org\/10.1111\/joor.12545.","journal-title":"J Oral Rehabil"},{"issue":"12","key":"2167_CR143","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s00520-023-08090-x","volume":"31","author":"C Rupe","year":"2023","unstructured":"Rupe C, Basco A, Gioco G, Patini R, Lucchese A, Miccich\u00e9 F, et al. Sodium-hyaluronate mouthwash on radiotherapy-induced xerostomia: a randomised clinical trial. Support Care Cancer. 2023;31(12):644. https:\/\/doi.org\/10.1007\/s00520-023-08090-x.","journal-title":"Support Care Cancer"},{"issue":"6","key":"2167_CR144","first-page":"869","volume":"27","author":"J Beuth","year":"2013","unstructured":"Beuth J, van Leendert R, Schneider B, Uhlenbruck G. Complementary medicine on side-effects of adjuvant hormone therapy in patients with breast cancer. In vivo (Athens, Greece). 2013;27(6):869\u201371.","journal-title":"In vivo (Athens, Greece)"},{"issue":"3","key":"2167_CR145","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/s2095-4964(17)60333-9","volume":"15","author":"G Heydarirad","year":"2017","unstructured":"Heydarirad G, Rezaeizadeh H, Choopani R, Mosavat SH, Ameri A. Efficacy of a traditional Persian medicine preparation for radiation-induced xerostomia: a randomized, open-label, active-controlled trial. J Integr Med. 2017;15(3):201\u20138. https:\/\/doi.org\/10.1016\/s2095-4964(17)60333-9.","journal-title":"J Integr Med"},{"key":"2167_CR146","doi-asserted-by":"publisher","first-page":"8537643","DOI":"10.1155\/2020\/8537643","volume":"2020","author":"AE Quimby","year":"2020","unstructured":"Quimby AE, Hogan D, Khalil D, Hearn M, Nault C, Johnson-Obaseki S. Coconut oil as a novel approach to managing radiation-induced xerostomia: a primary feasibility study. Int J Otolaryngol. 2020;2020:8537643. https:\/\/doi.org\/10.1155\/2020\/8537643.","journal-title":"Int J Otolaryngol"},{"key":"2167_CR147","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejon.2018.04.003","volume":"34","author":"M Charalambous","year":"2018","unstructured":"Charalambous M, Raftopoulos V, Paikousis L, Katodritis N, Lambrinou E, Vomvas D, et al. The effect of the use of thyme honey in minimizing radiation-induced oral mucositis in head and neck cancer patients: a randomized controlled trial. Eur J Oncol Nurs. 2018;34:89\u201397. https:\/\/doi.org\/10.1016\/j.ejon.2018.04.003.","journal-title":"Eur J Oncol Nurs"},{"issue":"3","key":"2167_CR148","first-page":"130","volume":"6","author":"G Chamani","year":"2017","unstructured":"Chamani G, Zarei MR, Mehrabani M, Nakhaee N, Kalaghchi B, Aghili M, et al. Assessment of systemic effects of ginger on salivation in patients with post-radiotherapy xerostomia. J Oral Health Oral Epidemiol. 2017;6(3):130.","journal-title":"J Oral Health Oral Epidemiol"},{"issue":"3","key":"2167_CR149","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/0194599816642418","volume":"155","author":"MK Chung","year":"2016","unstructured":"Chung MK, Kim DH, Ahn YC, Choi JY, Kim EH, Son Y-I. Randomized trial of vitamin C\/E complex for prevention of radiation-induced xerostomia in patients with head and neck cancer. Otolaryngol Head Neck Surg. 2016;155(3):423\u201330.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"Suppl 1","key":"2167_CR150","doi-asserted-by":"publisher","first-page":"E1232","DOI":"10.1002\/hed.24198","volume":"38","author":"C Heiser","year":"2016","unstructured":"Heiser C, Hofauer B, Scherer E, Schukraft J, Knopf A. Liposomal treatment of xerostomia, odor, and taste abnormalities in patients with head and neck cancer. Head Neck. 2016;38(Suppl 1):E1232\u20137. https:\/\/doi.org\/10.1002\/hed.24198.","journal-title":"Head Neck"},{"issue":"4","key":"2167_CR151","first-page":"12","volume":"18","author":"D Steinmann","year":"2012","unstructured":"Steinmann D, Eilers V, Beynenson D, Buhck H, Fink M. Effect of traumeel S on pain and discomfort in radiation-induced oral mucositis: a preliminary observational study. Altern Ther Health Med. 2012;18(4):12\u20138.","journal-title":"Altern Ther Health Med"},{"issue":"12","key":"2167_CR152","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/joor.12851","volume":"46","author":"P\u00c9 Dalbem","year":"2019","unstructured":"Dalbem P\u00c9, Batista CBB, Zanella GV, Martins VB, Macagnan FE. Effects of transcutaneous electrical nerve stimulation on the salivary flow of patients with hyposalivation induced by radiotherapy in the head and neck region\u2014a randomised clinical trial. J Oral Rehabil. 2019;46(12):1142\u201350. https:\/\/doi.org\/10.1111\/joor.12851.","journal-title":"J Oral Rehabil"},{"issue":"2","key":"2167_CR153","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ijrobp.2015.01.050","volume":"92","author":"RK Wong","year":"2015","unstructured":"Wong RK, Deshmukh S, Wyatt G, Sagar S, Singh AK, Sultanem K, et al. Acupuncture-like transcutaneous electrical nerve stimulation versus pilocarpine in treating radiation-induced xerostomia: results of RTOG 0537 phase 3 study. Int J Radiat Oncol Biol Phys. 2015;92(2):220\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.050.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02167-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-024-02167-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02167-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:02:45Z","timestamp":1732924965000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-024-02167-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":153,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2167"],"URL":"https:\/\/doi.org\/10.1186\/s40001-024-02167-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,30]]},"assertion":[{"value":"18 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The lead author is currently an associate editor of the European Journal of Medical Research. The authors declare no other competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"571"}}